INVO Bioscience Inc (INVO)
0.9836
-0.02
(-1.64%)
USD |
NASDAQ |
May 17, 16:00
0.9836
0.00 (0.00%)
After-Hours: 19:56
INVO Bioscience Research and Development Expense (Quarterly): 0.0059M for Dec. 31, 2023
Research and Development Expense (Quarterly) Chart
Historical Research and Development Expense (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 0.0059M |
September 30, 2023 | 0.0027M |
June 30, 2023 | 0.0838M |
March 31, 2023 | 0.0735M |
December 31, 2022 | 0.0738M |
September 30, 2022 | 0.1753M |
June 30, 2022 | 0.1908M |
March 31, 2022 | 0.1042M |
December 31, 2021 | 0.0638M |
September 30, 2021 | 0.0554M |
June 30, 2021 | 0.031M |
March 31, 2021 | 0.0663M |
December 31, 2020 | 0.2209M |
September 30, 2020 | 0.1126M |
June 30, 2020 | 0.0349M |
March 31, 2020 | 0.0301M |
December 31, 2019 | 0.00 |
September 30, 2019 | 0.00 |
June 30, 2019 | 0.00 |
March 31, 2019 | 0.00 |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | |
March 31, 2018 |
Date | Value |
---|---|
December 31, 2017 | |
September 30, 2017 | |
June 30, 2017 | |
March 31, 2017 | |
December 31, 2016 | |
September 30, 2016 | |
June 30, 2016 | |
March 31, 2016 | |
December 31, 2015 | |
September 30, 2015 | |
June 30, 2015 | |
March 31, 2015 | |
December 31, 2011 | |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.0027M |
September 30, 2009 | 0.00 |
June 30, 2009 | 0.00 |
March 31, 2009 | 0.005M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
Jun 2019
0.2209M
Maximum
Dec 2020
0.0697M
Average
0.0638M
Median
Dec 2021
Research and Development Expense (Quarterly) Benchmarks
Abbott Laboratories | 684.00M |
Perspective Therapeutics Inc | 6.08M |
Xtant Medical Holdings Inc | 0.492M |
Asensus Surgical Inc | 8.091M |
Catheter Precision Inc | 0.037M |